Skip to main content
Premium Trial:

Request an Annual Quote

Lion, GeneProt Ink Deal to Market Proteomics-Based Informatics

NEW YORK, March 14 - Lion Bioscience and GeneProt on Thursday said they will market an "integrated offering" that brings together GeneProt's proteomics technology with Lion's bioinformatics tools.

Terms of the three-year collaboration call for GeneProt to license Lion's SRS and DiscoveryCenter software together with its piSCOUT and pathSCOUT technologies. The North Brunswick, NJ-based company will also spend as much as $4.95 million on "related" but undisclosed services from Lion, it said. 
 

In return, Lion, of Heidelberg, Germany, will add GeneProt's proteomics technology to its in-house drug-discovery efforts. Lion will sweeten the deal by making a $7.5 million equity investment in GeneProt in exchange for 681,818 Series B preferred stock.

The goal of the collaboration is for GeneProt to use Lion's software to bolster its own "internal information platform," which it will then market bundled with Lion's software to customers that both firms share. This part of the bargain is left up to "Lion's discretion," the companies said.

Financial details of the deal were not disclosed.
 
This deal "yields the critical linkage between genomics and proteomics for life sciences companies, enabling them to consolidate intellectual property across multiple disciplines ... and analyze and apply it directly to the discovery of new ... proteins, protein drug targets, and protein biomarkers," Cedric Loiret-Bernal, GeneProt's CEO, said in a statement. 

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.